SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-22-008483
Filing Date
2022-05-09
Accepted
2022-05-09 16:07:58
Documents
61
Period of Report
2022-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q enta-20220331.htm   iXBRL 10-Q 2679956
2 EX-10.1 enta-ex10_1.htm EX-10.1 95422
3 EX-31.1 enta-ex31_1.htm EX-31.1 13422
4 EX-31.2 enta-ex31_2.htm EX-31.2 13413
5 EX-32.1 enta-ex32_1.htm EX-32.1 15031
6 GRAPHIC img215112886_0.jpg GRAPHIC 163367
  Complete submission text file 0000950170-22-008483.txt   8930394

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT enta-20220331_lab.xml EX-101.LAB 333815
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT enta-20220331_def.xml EX-101.DEF 122720
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT enta-20220331_cal.xml EX-101.CAL 43051
10 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT enta-20220331.xsd EX-101.SCH 34639
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT enta-20220331_pre.xml EX-101.PRE 262929
55 EXTRACTED XBRL INSTANCE DOCUMENT enta-20220331_htm.xml XML 1753593
Mailing Address 500 ARSENAL STREET WATERTOWN MA 02472
Business Address 500 ARSENAL STREET WATERTOWN MA 02472 617 607 0800
ENANTA PHARMACEUTICALS INC (Filer) CIK: 0001177648 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 0930
Type: 10-Q | Act: 34 | File No.: 001-35839 | Film No.: 22904942
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences